Scott E. Hensley, Ph.D. - Publications

Affiliations: 
2006 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Immunology, Molecular Biology, Microbiology Biology, Virology Biology

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, ... ... Hensley SE, et al. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell Host & Microbe. PMID 30795982 DOI: 10.1016/j.chom.2019.01.002  0.48
2016 Xue J, Chambers BS, Hensley SE, López CB. Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations. Frontiers in Microbiology. 7: 326. PMID 27047455 DOI: 10.3389/fmicb.2016.00326  0.76
2015 Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Reports. 12: 1-6. PMID 26119736 DOI: 10.1016/j.celrep.2015.06.005  0.76
2015 Shaffer SM, Joshi RP, Chambers BS, Sterken D, Biaesch AG, Gabrieli DJ, Li Y, Feemster KA, Hensley SE, Issadore D, Raj A. Multiplexed detection of viral infections using rapid in situ RNA analysis on a chip. Lab On a Chip. PMID 26113495 DOI: 10.1039/c5lc00459d  0.76
2015 Scott VL, Patel A, Villarreal DO, Hensley SE, Ragwan E, Yan J, Sardesai NY, Rothwell PJ, Extance JP, Caproni LJ, Weiner DB. Novel synthetic plasmid and doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Human Vaccines & Immunotherapeutics. 0. PMID 26091432 DOI: 10.1080/21645515.2015.1022008  0.76
2015 Hackett BA, Yasunaga A, Panda D, Tartell MA, Hopkins KC, Hensley SE, Cherry S. RNASEK is required for internalization of diverse acid-dependent viruses. Proceedings of the National Academy of Sciences of the United States of America. 112: 7797-802. PMID 26056282 DOI: 10.1073/pnas.1424098112  0.76
2014 Deng Z, Kim ET, Vladimirova O, Dheekollu J, Wang Z, Newhart A, Liu D, Myers JL, Hensley SE, Moffat J, Janicki SM, Fraser NW, Knipe DM, Weitzman MD, Lieberman PM. HSV-1 remodels host telomeres to facilitate viral replication. Cell Reports. 9: 2263-78. PMID 25497088 DOI: 10.1016/j.celrep.2014.11.019  0.76
2014 Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, ... ... Hensley SE, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proceedings of the National Academy of Sciences of the United States of America. 111: 15798-803. PMID 25331901 DOI: 10.1073/pnas.1409171111  0.76
2014 Brockhurst MA, Hensley SE. Editorial overview: viral evolution: exploring the frontiers of virus evolution in the lab, the field and the clinic. Current Opinion in Virology. 8: ix-x. PMID 25224393 DOI: 10.1016/j.coviro.2014.09.002  0.76
2014 Hensley SE. Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Current Opinion in Virology. 8: 85-9. PMID 25108824 DOI: 10.1016/j.coviro.2014.07.007  0.76
2014 Wolf AI, Strauman MC, Mozdzanowska K, Whittle JR, Williams KL, Sharpe AH, Weiser JN, Caton AJ, Hensley SE, Erikson J. Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus. Journal of Virology. 88: 11995-2005. PMID 25100838 DOI: 10.1128/JVI.01833-14  0.76
2014 Wolf AI, Strauman MC, Mozdzanowska K, Williams KL, Osborne LC, Shen H, Liu Q, Garlick D, Artis D, Hensley SE, Caton AJ, Weiser JN, Erikson J. Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease. Virology. 462: 254-65. PMID 24999050 DOI: 10.1016/j.virol.2014.06.019  0.76
2014 Chambers BS, Li Y, Hodinka RL, Hensley SE. Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. Journal of Virology. 88: 10986-9. PMID 24991002 DOI: 10.1128/JVI.01077-14  0.76
2014 Jiang J, Fisher EM, Hensley SE, Lustigman S, Murasko DM, Shen H. Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines. Vaccine. 32: 2696-702. PMID 24681229 DOI: 10.1016/j.vaccine.2014.03.046  0.76
2013 Myers JL, Wetzel KS, Linderman SL, Li Y, Sullivan CB, Hensley SE. Compensatory hemagglutinin mutations alter antigenic properties of influenza viruses. Journal of Virology. 87: 11168-72. PMID 23926344 DOI: 10.1128/JVI.01414-13  0.76
2013 Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, ... Hensley SE, et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. The Journal of Experimental Medicine. 210: 1493-500. PMID 23857983 DOI: 10.1084/jem.20130212  0.76
2013 Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, Stgeorge K, Plotkin JB, Hensley SE. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering. Journal of Virology. 87: 9904-10. PMID 23824816 DOI: 10.1128/JVI.01023-13  0.76
2013 Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host & Microbe. 13: 314-23. PMID 23498956 DOI: 10.1016/j.chom.2013.02.008  0.76
2011 Das SR, Hensley SE, David A, Schmidt L, Gibbs JS, Puigbò P, Ince WL, Bennink JR, Yewdell JW. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proceedings of the National Academy of Sciences of the United States of America. 108: E1417-22. PMID 22106257 DOI: 10.1073/pnas.1108754108  0.76
2011 Myers JL, Hensley SE. Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations. Expert Review of Anti-Infective Therapy. 9: 385-8. PMID 21504394 DOI: 10.1586/eri.11.2  0.76
2011 Hensley SE, Das SR, Gibbs JS, Bailey AL, Schmidt LM, Bennink JR, Yewdell JW. Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. Plos One. 6: e15190. PMID 21364978 DOI: 10.1371/journal.pone.0015190  0.76
2010 Das SR, Puigbò P, Hensley SE, Hurt DE, Bennink JR, Yewdell JW. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. Plos Pathogens. 6: e1001211. PMID 21124818 DOI: 10.1371/journal.ppat.1001211  0.76
2010 Hensley SE, Zanker D, Dolan BP, David A, Hickman HD, Embry AC, Skon CN, Grebe KM, Griffin TA, Chen W, Bennink JR, Yewdell JW. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. Journal of Immunology (Baltimore, Md. : 1950). 184: 4115-22. PMID 20228196 DOI: 10.4049/jimmunol.0903003  0.76
2009 Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (New York, N.Y.). 326: 734-6. PMID 19900932 DOI: 10.1126/science.1178258  0.76
2009 Hensley SE, Yewdell JW. Que sera, sera: evolution of the swine H1N1 influenza A virus. Expert Review of Anti-Infective Therapy. 7: 763-8. PMID 19735217 DOI: 10.1586/eri.09.62  0.76
2009 Hensley SE, Pinto AK, Hickman HD, Kastenmayer RJ, Bennink JR, Virgin HW, Yewdell JW. Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus. Journal of Virology. 83: 7357-60. PMID 19403665 DOI: 10.1128/JVI.00623-09  0.76
2009 Pichla-Gollon SL, Lin SW, Hensley SE, Lasaro MO, Herkenhoff-Haut L, Drinker M, Tatsis N, Gao GP, Wilson JM, Ertl HC, Bergelson JM. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo. Journal of Virology. 83: 5567-73. PMID 19279092 DOI: 10.1128/JVI.00405-09  0.76
2009 Wolf AI, Buehler D, Hensley SE, Cavanagh LL, Wherry EJ, Kastner P, Chan S, Weninger W. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 871-9. PMID 19124730  0.76
2008 Lasaro MO, Tatsis N, Hensley SE, Whitbeck JC, Lin SW, Rux JJ, Wherry EJ, Cohen GH, Eisenberg RJ, Ertl HC. Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses. Nature Medicine. 14: 205-12. PMID 18193057 DOI: 10.1038/nm1704  0.76
2008 Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, Loomis J, Barber GN, Bennink JR, Yewdell JW. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nature Immunology. 9: 155-65. PMID 18193049 DOI: 10.1038/ni1557  0.76
2008 Iparraguirre A, Tobias JW, Hensley SE, Masek KS, Cavanagh LL, Rendl M, Hunter CA, Ertl HC, von Andrian UH, Weninger W. Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide. Journal of Leukocyte Biology. 83: 610-20. PMID 18029397 DOI: 10.1189/jlb.0807511  0.76
2007 Lin SW, Hensley SE, Tatsis N, Lasaro MO, Ertl HC. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice. The Journal of Clinical Investigation. 117: 3958-70. PMID 18008010 DOI: 10.1172/JCI33138  0.76
2007 Hensley SE, Amalfitano A. Toll-like receptors impact on safety and efficacy of gene transfer vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1417-22. PMID 17551505 DOI: 10.1038/sj.mt.6300217  0.76
2007 Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood. 110: 1916-23. PMID 17510320 DOI: 10.1182/blood-2007-02-062117  0.76
2007 McCoy K, Tatsis N, Korioth-Schmitz B, Lasaro MO, Hensley SE, Lin SW, Li Y, Giles-Davis W, Cun A, Zhou D, Xiang Z, Letvin NL, Ertl HC. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. Journal of Virology. 81: 6594-604. PMID 17428852 DOI: 10.1128/JVI.02497-06  0.76
2007 Hensley SE, Cun AS, Giles-Davis W, Li Y, Xiang Z, Lasaro MO, Williams BR, Silverman RH, Ertl HC. Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 393-403. PMID 17235319 DOI: 10.1038/sj.mt.6300024  0.76
2007 Tatsis N, Blejer A, Lasaro MO, Hensley SE, Cun A, Tesema L, Li Y, Gao GP, Xiang ZQ, Zhou D, Wilson JM, Ertl HC. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 608-17. PMID 17228314 DOI: 10.1038/sj.mt.6300078  0.76
2005 Hensley SE, Giles-Davis W, McCoy KC, Weninger W, Ertl HC. Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. Journal of Immunology (Baltimore, Md. : 1950). 175: 6032-41. PMID 16237098  0.76
Show low-probability matches.